Clinical differences of c-Myc Expression in early stage gastric cancer: A retrospective study

Clinical differences of c-Myc Expression in early stage gastric cancer: A retrospective study - Clinical differences of c-Myc Expression in early stage gastric cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044040

Enrollment

100

Registered

2021-05-01

Start date

2020-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early gastric cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) early gastric caner (differentiated type) patient. 2) Patient who agree to participate in this trial by written informed consent. 3) Subjects aged over 20 years old.

Exclusion criteria

Exclusion criteria: Excluding mixed tissue types (cases in which a component of the secondary tissue type accounted for more than 10% of the total, or cases in which the component of the secondary tissue type was small but included poorly differentiated cancer).

Design outcomes

Primary

Measure	Time frame
The primary endpoint of the study is an hierarchical cluster analysis based on the scores obtained by c-Myc staining to clarify the characteristics of each group.	—

Secondary

Measure	Time frame
The secondary endpoints of the study are a c-Myc expression rate in early gastric neoplasia based on the WHO classification, and the comparison of c-Myc expression intensity between mucosal and invasive areas in submucosal invasive carcinoma.	—

Countries

Japan

Contacts

Public ContactNoriyuki Arakawa

Takeda general hospital Department of Gastroenterology

imu_nori0111@yahoo.co.jp0242-27-5511

Outcome results